Dr Jack Tan
Fellow by Special Election
Jack Tan is a Fellow by Special Election
Jack Tan is a Fellow by Special Election at St Edmund Hall.
Prior to his appointment as a Fellow by Special Election, Jack was the EPA Cephalosporin Early Career Teaching and Research Fellow at St Edmund Hall (2019-2022). Currently, he is a senior scientist in the Alain Townsend Lab at the Weatherall Institute of Molecular Medicine focusing on developing novel vaccines and therapeutic monoclonal antibodies for emerging infectious diseases and understanding the immunology against infectious diseases. He is also a Project Manager of the Caltech-Oxford-Ingenza-CPI consortium which is funded ($30M) by the Coalition of Epidemic Preparedness Innovations (CEPI) to develop a novel pan SARS-like betacoronavirus vaccine that is designed to induce cross-reactive antibodies against all SARS-CoV-2 variants and other animal SARS-like betacoronavirus that have the potential to cause a pandemic in the future. A human trial of the vaccine is expected to start in 2024.
Where next?
